What does CUSIP 45826J105 represent in this 13F holders report?

CUSIP 45826J105 is the security identifier for NTLA - Intellia Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held NTLA - Intellia Therapeutics, Inc. - Common Stock in Q1 2017?

73 institutional investors reported NTLA - Intellia Therapeutics, Inc. - Common Stock for Q1 2017. Use the holders table for investor-level position and value details.

Intellia Therapeutics, Inc. - Common Stock (NTLA)

CUSIP: 45826J105

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class: Equity / Common Stock
Shares outstanding: 118,202,207
Total 13F shares: 16,738,696
Share change: -781,915
Total reported value: $235,847,748
Price per share: $14.09
Number of holders: 73
Value change: -$10,683,400
Number of buys: 42
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 45826J105?
CUSIP 45826J105 identifies NTLA - Intellia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2017
Previous quarter: Q4 2016

Recent filing periods for CUSIP 45826J105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NTLA - Intellia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	4%	4,765,481	$62,475,000	—	31 Dec 2016	13F
Atlas Venture Associates IX, LLC	13F	Company	3.7%	4,429,788	$58,075,000	—	31 Dec 2016	13F
ORBIMED ADVISORS LLC	13F	Company	2.3%	2,662,180	$34,901,000	—	31 Dec 2016	13F
BAKER BROS. ADVISORS LP	13F	Company	0.9%	1,062,120	$13,924,000	—	31 Dec 2016	13F
VANGUARD GROUP INC	13F	Company	0.74%	870,783	$11,416,000	—	31 Dec 2016	13F
Temasek Holdings (Private) Ltd	13F	Company	0.67%	790,527	$10,364,000	—	31 Dec 2016	13F
BlackRock Fund Advisors	13F	Company	0.6%	704,350	$9,234,000	—	31 Dec 2016	13F
Foresite Capital Management III, LLC	13F	Company	0.6%	703,563	$9,224,000	—	31 Dec 2016	13F
FRANKLIN RESOURCES INC	13F	Company	0.25%	300,000	$3,933,000	—	31 Dec 2016	13F
Artal Group S.A.	13F	Company	0.21%	250,000	$3,278,000	—	31 Dec 2016	13F
MORGAN STANLEY	13F	Company	0.21%	245,480	$3,218,000	—	31 Dec 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.14%	162,703	$2,133,000	—	31 Dec 2016	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.13%	158,551	$2,079,000	—	31 Dec 2016	13F
Alyeska Investment Group, L.P.	13F	Company	0.12%	140,000	$1,835,000	—	31 Dec 2016	13F
SABBY MANAGEMENT, LLC	13F	Company	0.11%	130,000	$1,704,000	—	31 Dec 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.11%	128,308	$1,682,000	—	31 Dec 2016	13F
STATE STREET CORP	13F	Company	0.08%	92,355	$1,211,000	—	31 Dec 2016	13F
NORTHERN TRUST CORP	13F	Company	0.07%	77,959	$1,022,000	—	31 Dec 2016	13F
Tekla Capital Management LLC	13F	Company	0.06%	71,842	$942,000	—	31 Dec 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	71,804	$941,000	—	31 Dec 2016	13F
NORGES BANK	13F	Company	0.06%	67,571	$886,000	—	31 Dec 2016	13F
Neuberger Berman Group LLC	13F	Company	0.04%	45,736	$600,000	—	31 Dec 2016	13F
SG Americas Securities, LLC	13F	Company	0.03%	36,794	$482,000	—	31 Dec 2016	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.03%	36,415	$477,000	—	31 Dec 2016	13F
Bank of New York Mellon Corp	13F	Company	0.03%	29,994	$394,000	—	31 Dec 2016	13F
ARK Investment Management LLC	13F	Company	0.02%	26,544	$348,000	—	31 Dec 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.02%	25,834	$339,000	—	31 Dec 2016	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	25,800	$338,000	—	31 Dec 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	25,420	$333,000	—	31 Dec 2016	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	25,364	$333,000	—	31 Dec 2016	13F
ProShare Advisors LLC	13F	Company	0.02%	24,902	$326,000	—	31 Dec 2016	13F
Swiss National Bank	13F	Company	0.02%	20,700	$271,000	—	31 Dec 2016	13F
Virtu KCG Holdings LLC	13F	Company	0.02%	20,545	$269,000	—	31 Dec 2016	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.01%	14,673	$192,000	—	31 Dec 2016	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	14,343	$188,000	—	31 Dec 2016	13F
CREDIT SUISSE AG/	13F	Company	0.01%	12,371	$162,000	—	31 Dec 2016	13F
UBS Group AG	13F	Company	0.01%	11,455	$150,000	—	31 Dec 2016	13F
BARCLAYS PLC	13F	Company	0.01%	11,213	$148,000	—	31 Dec 2016	13F
TEACHERS ADVISORS, LLC	13F	Company	0.01%	10,990	$144,000	—	31 Dec 2016	13F
Commonwealth Equity Services, Inc	13F	Company	0.01%	10,800	$142,000	—	31 Dec 2016	13F
ClariVest Asset Management LLC	13F	Company	0.01%	9,077	$119,000	—	31 Dec 2016	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	8,915	$117,000	—	31 Dec 2016	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	7,200	$94,000	—	31 Dec 2016	13F
Nationwide Fund Advisors	13F	Company	0%	4,539	$60,000	—	31 Dec 2016	13F
DEUTSCHE BANK AG\	13F	Company	0%	4,438	$57,000	—	31 Dec 2016	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	4,014	$53,000	—	31 Dec 2016	13F
Wildcat Capital Management, LLC	13F	Company	0%	3,542	$46,000	—	31 Dec 2016	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	3,282	$43,000	—	31 Dec 2016	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	3,300	$42,000	—	31 Dec 2016	13F
STRS OHIO	13F	Company	0%	3,200	$41,000	—	31 Dec 2016	13F

Institutional Holders of Intellia Therapeutics, Inc. - Common Stock (NTLA) as of Q1 2017

As of 31 Mar 2017, Intellia Therapeutics, Inc. - Common Stock (NTLA) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,738,696 shares. The largest 10 holders included FMR LLC, Atlas Venture Associates IX, LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, GMT CAPITAL CORP, FRANKLIN RESOURCES INC, and Artal Group S.A.. This page lists 73 institutional shareholders reporting positions in this security for the Q1 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders

Q1 2017 holders

Holder diff

Investor	Q4 2016 Shares	Q1 2017 Shares	Share Diff	Share Chg %	Q4 2016 Value $	Q1 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.